rs1139583
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001395002.1(MAP4K4):āc.1254A>Gā(p.Glu418Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.162 in 1,549,936 control chromosomes in the GnomAD database, including 21,182 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.15 ( 1722 hom., cov: 32)
Exomes š: 0.16 ( 19460 hom. )
Consequence
MAP4K4
NM_001395002.1 synonymous
NM_001395002.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.807
Genes affected
MAP4K4 (HGNC:6866): (mitogen-activated protein kinase kinase kinase kinase 4) The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 2-101855997-A-G is Benign according to our data. Variant chr2-101855997-A-G is described in ClinVar as [Benign]. Clinvar id is 1183614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.807 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP4K4 | NM_001395002.1 | c.1254A>G | p.Glu418Glu | synonymous_variant | 13/33 | ENST00000324219.9 | NP_001381931.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP4K4 | ENST00000324219.9 | c.1254A>G | p.Glu418Glu | synonymous_variant | 13/33 | 5 | NM_001395002.1 | ENSP00000313644.6 |
Frequencies
GnomAD3 genomes AF: 0.146 AC: 22146AN: 152062Hom.: 1721 Cov.: 32
GnomAD3 genomes
AF:
AC:
22146
AN:
152062
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.150 AC: 22990AN: 153544Hom.: 1888 AF XY: 0.157 AC XY: 12747AN XY: 81408
GnomAD3 exomes
AF:
AC:
22990
AN:
153544
Hom.:
AF XY:
AC XY:
12747
AN XY:
81408
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.164 AC: 228656AN: 1397756Hom.: 19460 Cov.: 32 AF XY: 0.166 AC XY: 114205AN XY: 689492
GnomAD4 exome
AF:
AC:
228656
AN:
1397756
Hom.:
Cov.:
32
AF XY:
AC XY:
114205
AN XY:
689492
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.146 AC: 22147AN: 152180Hom.: 1722 Cov.: 32 AF XY: 0.146 AC XY: 10881AN XY: 74392
GnomAD4 genome
AF:
AC:
22147
AN:
152180
Hom.:
Cov.:
32
AF XY:
AC XY:
10881
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
654
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at